Evidence map›Paper›PMID 30712813›Full record

Trial reportSchizophrenia research2019

Oxytocin does not improve working memory in schizophrenia.

Ellen R Bradley, Adrienne van Nieuwenhuizen, Samantha Abram, Andrea N Niles, Joshua D Woolley

Open access · greenAbstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in Schizophrenia research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ellen R BradleyUniversity of California, San Francisco, CA, United States of America; San Francisco Veteran's Affairs Medical Center, San Francisco, CA, United States of America. Electronic address: ellen.bradley@ucsf.edu.
Adrienne van NieuwenhuizenUniversity of California, San Francisco, CA, United States of America; San Francisco Veteran's Affairs Medical Center, San Francisco, CA, United States of America.
Samantha AbramUniversity of California, San Francisco, CA, United States of America; San Francisco Veteran's Affairs Medical Center, San Francisco, CA, United States of America.
Andrea N NilesUniversity of California, San Francisco, CA, United States of America; San Francisco Veteran's Affairs Medical Center, San Francisco, CA, United States of America.
Joshua D WoolleyUniversity of California, San Francisco, CA, United States of America; San Francisco Veteran's Affairs Medical Center, San Francisco, CA, United States of America.
San Francisco VA Medical Center · US

Funding

TRAINING THE NEXT GENERATION OF MENTAL HEALTH RESEARCHERSR25MH060482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DANIEL H MATHALON, Susan M. Voglmaier · 2000 to 2026
$5.2M
CSRD VA IK2 CX000758NIMH NIH HHS R25 MH060482
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Schizophrenic PsychologyAdultCross-Over StudiesFemaleHealthy VolunteersHumansMaleMemory, Short-TermMiddle AgedOxytocicsOxytocinSchizophreniaTreatment OutcomeOxytocicsOxytocinCognitionOxytocinSchizophreniaWorking memory

Identifiers

PMID30712813
PMCPMC7297462
OpenAlexW2911246695

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.